Integra Lifesciences Holdings Corp

Most Recent

  • uploads///STOCK PRICE
    Company & Industry Overviews

    Will Dentsply Sirona Stock Recover from Recent Declines?

    On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share.

    By Sarah Collins
  • uploads///RTG
    Company & Industry Overviews

    How Does Medtronic’s Restorative Therapies & Diabetes Group Look?

    Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.

    By Daniel Collins
  • uploads///stock price
    Company & Industry Overviews

    Reading Dentsply Sirona’s Recent Stock Performance

    On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.

    By Sarah Collins
  • uploads///DIABETES
    Company & Industry Overviews

    Developments in J&J’s Medical Device Business Could Drive Growth

    In October 2017, Johnson & Johnson (JNJ) exited its insulin pump business, which was experiencing a decline in sales due to the intense competition in the insulin pump market.

    By Sarah Collins
  • uploads///medical device segment growth strategy
    Earnings Report

    J&J Completed the Divestiture of Its Neurosurgery Business

    Johnson & Johnson’s (JNJ) medical device business has been restructuring in order to focus on higher growth areas with potential expansion opportunities.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Intuitive Surgical’s Recent Stock Split: The Market Reaction

    On October 6, 2017, Intuitive Surgical will start trading on a split-adjusted basis. It has scheduled a stock split for its shares in a ratio of 3:1.

    By Sarah Collins
  • uploads///leading portfolio
    Company & Industry Overviews

    Developments in Dentsply Sirona’s Digital Dentistry Portfolio

    On September 20, 2017, Dentsply Sirona (XRAY) announced an enhancement to its Galileos Implant software.

    By Sarah Collins
  • uploads///leading portfolio
    Company & Industry Overviews

    Dentsply Sirona’s Newly Launched Cerec Zirconia Meso Block

    In August 2017, Dentsply Sirona (XRAY) launched its Cerec Zirconia Meso Block for creating customized screw-retained crowns.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Analysts Are Recommending for Dentsply Sirona

    According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Dentsply Sirona?

    Based on the recommendations of 16 brokerage companies, around 63% (or ten) of the analysts provided a “buy” recommendation for Dentsply Sirona.

    By Sarah Collins
  • uploads///PROJECTIONS
    Company & Industry Overviews

    Discussing Dentsply Sirona’s Updated 2017 Guidance

    Dentsply Sirona made a downward revision to its fiscal 2017 guidance during the company’s 2Q17 earnings results announcement on August 9, 2017.

    By Sarah Collins
  • uploads///REVENUES BY SEGMENT
    Company & Industry Overviews

    Dental and Healthcare Consumables Grew but Missed Expectations in 2Q17

    In 2Q17, Dentsply Sirona’s (XRAY) Dental and Healthcare Consumables business contributed ~56% to the company’s total revenues and registered sales of ~$554 million.

    By Sarah Collins
  • uploads///segment wise revenues
    Company & Industry Overviews

    Inside JNJ’s Inorganic Strategy in Medical Devices: The Latest Acquisitions

    In February 2017, JNJ completed its acquisition of Abbott Medical Optics, and the parent company’s 1Q17 results included ~$124 million of Abbott Medical Optics’ sales.

    By Sarah Collins
  • uploads///profitability
    Earnings Report

    How Dentsply Sirona’s Profitability Metrics Looked in 1Q17

    Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.

    By Sarah Collins
  • uploads///revenues by segment
    Earnings Report

    Dentsply Sirona’s New Growth Strategy to Accelerate Digital Dentistry Penetration

    Dentsply Sirona is the largest dental equipment and solutions manufacturer in the United States. Digital dentistry is a megatrend in the market.

    By Sarah Collins
  • uploads///analyst recommendations
    Healthcare

    What Are Analysts’ Recommendations for Dentsply Sirona?

    According to a Bloomberg survey, 43% of the analysts gave Dentsply Sirona a “buy” rating and ~57% gave it a “hold” rating. It didn’t have any “sell” ratings.

    By Sarah Collins
  • uploads///combined business profile
    Healthcare

    Why Is Dentsply Sirona Acquiring MIS Implants?

    Dentsply Sirona is acquiring MIS due to its established brand and broad portfolio of implants and related products.

    By Sarah Collins
  • uploads///product portfolio
    Company & Industry Overviews

    A Brief Look at Dentsply Sirona’s Business Model

    Dentsply Sirona (XRAY) offers a broad portfolio of dental equipment and consumables that have urological and surgical applications.

    By Sarah Collins
  • uploads///combined business profile
    Company & Industry Overviews

    Introducing Dentsply Sirona, a Leading Dental Products Manufacturer

    Dentsply Sirona (XRAY) is the largest manufacturer of dental equipment and technologies in the world. The company was formed in February 2016.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.